Latest / Equity Mates Investing Podcast
Bitcoin is down bad, Ren’s portfolio shake-up & Pimp my Portfolio with Matt Ingram
Bitcoin has slid into bear-market territory and we dig into the what's really driving the sell-off.
Plus, we also look at a surprising shift in the US: obesity rates are finally dropping, driven by the explosive rise of GLP-1 drugs like Ozempic. What does it mean for stocks like Eli Lilly and Novo Nordisk?
That’s not all in this episode:
Ren rebuilds his core portfolio
We compare two ex-US ETFs that look similar but are wildly different under the hood
And Matt Ingram helps Josh refine his stock-heavy portfolio
To submit your portfolio for the show, head to equitymates.com/contact or…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.